References
- Polat M, Yüksel S, Şahin NÜ. Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab. Hum Vaccin Immunother., 1-1.
- Food and Drug Administration. Soliris product insert. In: US Department of health and human services food and drug administration. Silver Spring, MD., 2017.
- McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR. High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine. MMWR Morbidity and Mortality Weekly Report. 2017;66:734–7. doi:10.15585/mmwr.mm6627e1. PMID:28704351.
- Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report. 2013;62:1–28. PMID:23302815.
- Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR. Use of Serogroup B Meningococcal Vaccines in Persons Aged >/ = 10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morbidity and Mortality Weekly Report. 2015;64:608–12.
- Parikh SR, Lucidarme J, Bingham C, Warwicker P, Goodship T, Borrow R, Ladhani SN. Meningococcal B vaccine failure with a penicillin-resistant strain in a young adult on long-term eculizumab. Pediatrics. 2017;140(3). doi:10.1542/peds.2016-2452.
- Konar M, Granoff DM. Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults. Blood. 2017 Aug 17;130(7):891–9. doi:10.1182/blood-2017-05-781450.
- Cullinan N, Gorman KM, Riordan M, Waldron M, Goodship TH, Awan A. Case report: benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndrome. Pediatrics. 2015;135(6). doi:10.1542/peds.2014-3503. PMID:25941307.
- Kaplon H, Reichert JM. Antibodies to watch in 2018. mAbs. 2018;10(2):183–203. doi:10.1080/19420862.2018.1415671. PMID:29300693.